Given that Clusters 3 and 4 were identified as being associated with poor outcome, integration of the cancer-associated transcript (e.g., VWF) levels and/or TME immunocyte (e.g., CD8+T-cells) ratios into this model may be useful in further refinement of these MCL subgroups. The gene discussed is CD8A; the disease is cancer.